Treatment
Learn how primary immunodeficiency (PI) is treated, from recurring treatments like immunoglobulin (Ig) replacement therapy to long-lasting treatments like hematopoietic stem cell transplant (HSCT).
The more you understand about primary immunodeficiency (PI), the better you can live with the disease or support others in your life with PI. Learn more about PI, including the various diagnoses and treatment options.
Living with primary immunodeficiency (PI) can be challenging, but you’re not alone—many people with PI lead full and active lives. With the right support and resources, you can, too.
Be a hero for those with PI. Change lives by promoting primary immunodeficiency (PI) awareness and taking action in your community through advocacy, donating, volunteering, or fundraising.
Whether you’re a clinician, researcher, or an individual with primary immunodeficiency (PI), IDF has resources to help you advance the field. Get details on surveys, grants, and clinical trials.
Learn how primary immunodeficiency (PI) is treated, from recurring treatments like immunoglobulin (Ig) replacement therapy to long-lasting treatments like hematopoietic stem cell transplant (HSCT).
Ig replacement therapy provides antibodies that help prevent infection in those with antibody deficiencies.
When primary immunodeficiency is likely to cause significant harm or death, HSCT, more commonly known as a bone marrow transplant (BMT), may be the best treatment option.
Gene therapy is in clinical trials for several types of PI and offers an alternative to HSCT when a suitable donor is not available.
Ig replacement therapy, HSCT, and gene therapy are not the only treatments for PI, some types of PI have treatments specific to them. Explore our pages on different types of PI to learn about specific treatments.
Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.
The Immune Deficiency Foundation improves the diagnosis, treatment, and quality of life for every person affected by primary immunodeficiency.
We foster a community that is connected, engaged, and empowered through advocacy, education, and research.
Combined Charity Campaign | CFC# 66309